Company Filing History:
3 out of 446 
2 out of 2 
1 out of 12 Years Active: 2006-2024
Title: Carlos A Guzman: Innovator in Hepatitis C Research
Introduction
Carlos A Guzman is a prominent inventor based in Braunschweig, Germany. He has made significant contributions to the field of immunology, particularly in the development of vaccines for hepatitis C virus (HCV). With a total of 4 patents, his work has the potential to impact public health significantly.
Latest Patents
Guzman's latest patents focus on immunogenic compositions for hepatitis C virus. These compositions include hepatitis C virus (HCV) E1E2 heterodimers, HCV E2, or HCV E1, combined with an adjuvant such as a cyclic dinucleotide or an archaeosome. The methods disclosed aim to induce an immune response in individuals against HCV by administering an effective amount of these immunogenic compositions.
Career Highlights
Throughout his career, Carlos A Guzman has worked with esteemed institutions, including the University of Alberta and the Helmholtz Center for Infection Research. His research has been pivotal in advancing the understanding and treatment of hepatitis C.
Collaborations
Guzman has collaborated with notable figures in the field, including Michael Houghton and Abdolamir Landi. These partnerships have further enriched his research and contributed to the development of innovative solutions for combating hepatitis C.
Conclusion
Carlos A Guzman stands out as a key inventor in the fight against hepatitis C, with his innovative patents and collaborations paving the way for future advancements in immunology. His work continues to inspire and influence the field significantly.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.